Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karel Zitterbart is active.

Publication


Featured researches published by Karel Zitterbart.


Reports of Practical Oncology & Radiotherapy | 2006

Craniospinal irradiation of medulloblastoma in the supine position

Pavel Šlampa; Karel Zitterbart; Ladislav Dušek; Jana Ruzickova; Olga Magnová; Petr Čoupek; Petra Hübnerova; Barbora Ondrová; Blazena Syptakova

Summary Background Medulloblastoma, a primitive neuroectodermal tumour growing in the cerebellum, is one of the most sensitive childhood brain tumours to radiation therapy. The most common malignant CNS tumour of children is medulloblastoma with an overall incidence among children aged 0–19 years of 16–20% of all paediatric brain tumours. Radiotherapy is an essential method of treatment for these tumours, but surgery is the primary treatment of choice in medulloblastoma. Postoperative radiation therapy has a significant impact on local control and overall survival. Aim Medulloblastoma is the most common malignant brain tumour of children. The tumour is sensitive to chemotherapy and radiotherapy. Radiotherapy is an essential method of treatment for these tumours, but surgery is the primary treatment of choice in medulloblastoma. Materials/Methods Between January 1997 and March 2005 there were in this study post-operatively irradiated a total number of 33 paediatric patients aged under 15 years (median age 6.6 years) with medulloblastoma. All tumours were histologically proven and were located infratentorially in the posterior fossa. All of the patients were irradiated with a dose of 24–36 Gy to the whole craniospinal axis and boost with conformal therapy restricted to the tumour bed to the total dose of 50–54 Gy (30–36 Gy “high risk”, 24–30 Gy “standard risk” group). 26 patients (78%) received chemotherapy. Patients with craniospinal irradiation were placed in the supine position and fixed by a vacuum-form body immobilizer and head mask. Irradiation was performed using standard fractionation (5 fractions per week) with a single dose of 1.5–1.8 Gy for craniospinal axis by photon beam (6MV) of the linear accelerator. Results The median overall survival for the whole group was 55.3 months. The median disease-free survival was 20.6 months. The overall survival rate at 5 years was 41%; 8 patients (24%) died. No relationship was found between survival and age, sex or tumour size. Endocrine deficits occurred in 30% (8 patients of the group were hypothyroid, growth retardation occurred in 7 patients). Conclusions Results of overall and disease-free survival and side-effects of the technique of craniospinal axis irradiation in supine position are comparable with results of the technique in prone position.


Archive | 2016

Objective response to vemurafenib in a child treated formetastatic desmoplastic infantile

Zdeněk Pavelka; Jitka Berkovcova; Jarmila Skotáková; Karel Zitterbart; Jaroslav Štěrba


Neuro-oncology | 2016

LG-60OBJECTIVE RESPONSE TO VEMURAFENIB IN A CHILD TREATED FOR METASTATIC DESMOPLASTIC INFANTILE ASTROCYTOMA

Zdenek Pavelka; Jitka Berkovcova; Jarmila Skotáková; Karel Zitterbart; Jaroslav Sterba


Klinická onkologie | 2016

Identifikace rodiny s nosičstvím germinální delece genu SUFU napodkladě diagnózy desmoplastického meduloblastomu u batolete

J. Šoukalová; Klára Vejmělková; Tereza Cermanová; K. Kašíková; Aneta Mikulášová; Helena Janyšková; Kristýna Melichárková; Zdenek Pavelka; Marta Ježová; Šárka Pospíšilová; Petr Kuglík; Iveta Valášková; Renata Gaillyová; Jaroslav Štěrba; Karel Zitterbart


Klinická onkologie | 2015

Profil aktivace receptorových tyrozinkináz a mitogenemaktivovaných proteinkináz v terapii Maffucciho syndromu

Kristýna Melichárková; Jakub Neradil; Peter Múdry; Karel Zitterbart; Radka Obermannová; Jarmila Skotáková; Renata Veselská; Jaroslav Štěrba


Archive | 2012

CHORIONIC GONADOTROPHIN PRODUCING BRAIN GERMINOMA AS A CAUSE OFPRECOCIOUS PSEUDOPUBERTY

Eva Brichtová; Zdeněk Pavelka; Karel Zitterbart; Jaroslav Štěrba; Tomáš Svoboda


Archive | 2011

A new set of antibodies recognizing p53 homologues, p63 andp73.

Marta Nekulová; Karel Zitterbart; Philip J. Coates; Bořivoj Vojtěšek


Archive | 2011

Analysis of HGG-02 cell line with loss of EGFR gene copyderived from childhood glioblastoma multirme.

Jan Skoda; Jakub Neradil; Tomáš Loja; Karel Zitterbart; Zdeněk Pavelka; Eva Brichtová; Jana Šmardová; Iveta Valášková; Markéta Hermanová; Jaroslav Štěrba; Renata Veselská


Archive | 2011

Identification of cells with cancer stem cell phenotype inrhabdomyosarcoma.

Markéta Hermanová; Iva Zambo; Jiří Šána; Jan Skoda; Jakub Neradil; Petr Chlapek; Peter Múdry; Alzbeta Vasikova; Karel Zitterbart; Jaroslav Štěrba; Renata Veselská


Archive | 2011

N-terminal P73 protein isoforms in medulloblastoma cell andtheir involvement in retinoic acid-induced differentation.

Karel Zitterbart; Lucia Dobrucká; Petr Chlapek; Jakub Neradil; Jan Skoda; Jaroslav Štěrba

Collaboration


Dive into the Karel Zitterbart's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge